Back
Biogen Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer19.jpg)
Watch this free video on trading overnight options
Get the free overnight options training here.
Sell
33
BIIB
Biogen
Last Price:
225.61
Seasonality Move:
7.99%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer16.jpg)
Buffet, Bloomberg & 48 Congress Members Are Buying 1 Sector
Click here for the details.Biogen Price Quote
$225.61
-0.04 (0.45%)
(Updated: July 6, 2024 at 5:39 AM ET)
Biogen Key Stats
Sell
33
Biogen (BIIB)
is a Sell
Day range:
$223.05 - $226.42
52-week range:
$189.44 - $286.54
Dividend yield:
0%
P/E ratio:
28.31
P/S ratio:
3.40
P/B ratio:
2.16%
Volume:
458.2K
Avg. volume:
1M
1-year change:
-21.07%
Market cap:
$32.9B
Revenue:
$9.8B
EPS:
$8.01
How Much Does Biogen Make?
Is Biogen Growing As A Company?
Biogen Stock Price Performance
What Is Biogen 52-Week High & Low?
Biogen Price To Free Cash Flow
-
Is Biogen Stock Overvalued?
Biogen is trading at a price to free cash flow ratio of 25.57 -
Is Biogen Stock Undervalued?
Biogen EV to Free Cash Flow ratio is 29.83 -
What Is Biogen’s Price Earnings Growth Ratio?
BIIB PEG ratio is 0.00 -
Is Biogen Trading At A Premium To Earnings?
Biogen EV to EBIT ratio is 24.30
Is It Risky To Buy Biogen?
Is Biogen Cash Flow Positive?
Biogen Return On Invested Capital
Biogen Earnings Date & Stock Price
-
What Is Biogen's Stock Price Today?
A single share of BIIB can be purchased today for 225.65 -
What Is Biogen’s Stock Symbol?
Biogen trades on the S&P500 under the ticker symbol: BIIB -
When Is Biogen’s Next Earnings Date?
The next quarterly earnings date for Biogen is scheduled on July 25, 2024 -
When Is BIIB's next ex-dividend date?
Biogen's next ex-dividend date is June 18, 2020 -
How To Buy Biogen Stock?
You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Biogen Competitors
Biogen Dividend Yield
Data Unavailable
Biogen Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 1.12% | 0% |
Revenue: | -7% | 0% |
Analyst Recommendations
Buy Recommendations: | 16 |
---|---|
Hold Recommendations: | 10 |
Sell Recommendations: | 0 |
Price Target: | 283.15 |
Upside from Last Price: | 25.48% |